330 related articles for article (PubMed ID: 24149930)
1. Phase 3 randomized controlled study of gastroretentive gabapentin for the treatment of moderate-to-severe hot flashes in menopause.
Pinkerton JV; Kagan R; Portman D; Sathyanarayana R; Sweeney M;
Menopause; 2014 Jun; 21(6):567-73. PubMed ID: 24149930
[TBL] [Abstract][Full Text] [Related]
2. Gastroretentive gabapentin (G-GR) formulation reduces intensity of pain associated with postherpetic neuralgia (PHN).
Sang CN; Sathyanarayana R; Sweeney M;
Clin J Pain; 2013 Apr; 29(4):281-8. PubMed ID: 22801243
[TBL] [Abstract][Full Text] [Related]
3. Gabapentin for the treatment of menopausal hot flashes: a randomized controlled trial.
Butt DA; Lock M; Lewis JE; Ross S; Moineddin R
Menopause; 2008; 15(2):310-8. PubMed ID: 17917611
[TBL] [Abstract][Full Text] [Related]
4. Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: a systematic review and meta-analysis.
Toulis KA; Tzellos T; Kouvelas D; Goulis DG
Clin Ther; 2009 Feb; 31(2):221-35. PubMed ID: 19302896
[TBL] [Abstract][Full Text] [Related]
5. Use of gabapentin for the management of natural or surgical menopausal hot flashes.
Hayes LP; Carroll DG; Kelley KW
Ann Pharmacother; 2011 Mar; 45(3):388-94. PubMed ID: 21343402
[TBL] [Abstract][Full Text] [Related]
6. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial.
Pandya KJ; Morrow GR; Roscoe JA; Zhao H; Hickok JT; Pajon E; Sweeney TJ; Banerjee TK; Flynn PJ
Lancet; 2005 Sep 3-9; 366(9488):818-24. PubMed ID: 16139656
[TBL] [Abstract][Full Text] [Related]
7. Gabapentin, estrogen, and placebo for treating hot flushes: a randomized controlled trial.
Reddy SY; Warner H; Guttuso T; Messing S; DiGrazio W; Thornburg L; Guzick DS
Obstet Gynecol; 2006 Jul; 108(1):41-8. PubMed ID: 16816054
[TBL] [Abstract][Full Text] [Related]
8. Once-daily gastroretentive gabapentin for postherpetic neuralgia: integrated efficacy, time to onset of pain relief and safety analyses of data from two phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
Rauck RL; Irving GA; Wallace MS; Vanhove GF; Sweeney M
J Pain Symptom Manage; 2013 Aug; 46(2):219-28. PubMed ID: 23149085
[TBL] [Abstract][Full Text] [Related]
9. A gastroretentive gabapentin formulation for the treatment of painful diabetic peripheral neuropathy: efficacy and tolerability in a double-blind, randomized, controlled clinical trial.
Sandercock D; Cramer M; Biton V; Cowles VE
Diabetes Res Clin Pract; 2012 Sep; 97(3):438-45. PubMed ID: 22497967
[TBL] [Abstract][Full Text] [Related]
10. Use of gabapentin in patients experiencing hot flashes.
Brown JN; Wright BR
Pharmacotherapy; 2009 Jan; 29(1):74-81. PubMed ID: 19113798
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of once-daily gastroretentive gabapentin in patients with postherpetic neuralgia aged 75 years and over.
Gupta A; Li S
Drugs Aging; 2013 Dec; 30(12):999-1008. PubMed ID: 24163280
[TBL] [Abstract][Full Text] [Related]
12. Steady-state pharmacokinetics of gabapentin after administration of a novel gastroretentive extended-release formulation in postmenopausal women with vasomotor symptoms.
Cowles VE; Gordi T; Hou SY
Clin Drug Investig; 2012 Sep; 32(9):593-601. PubMed ID: 22775354
[TBL] [Abstract][Full Text] [Related]
13. Gabapentin: a pooled analysis of adverse events from three clinical trials in patients with postherpetic neuralgia.
Parsons B; Tive L; Huang S
Am J Geriatr Pharmacother; 2004 Sep; 2(3):157-62. PubMed ID: 15561647
[TBL] [Abstract][Full Text] [Related]
14. Effects of gabapentin on sleep in menopausal women with hot flashes as measured by a Pittsburgh Sleep Quality Index factor scoring model.
Yurcheshen ME; Guttuso T; McDermott M; Holloway RG; Perlis M
J Womens Health (Larchmt); 2009 Sep; 18(9):1355-60. PubMed ID: 19708803
[TBL] [Abstract][Full Text] [Related]
15. Long-term safety of gastroretentive gabapentin in postherpetic neuralgia patients.
Jensen MP; Irving G; Rauck R; Wallace M; Sweeney M; Vanhove GF
Clin J Pain; 2013 Sep; 29(9):770-4. PubMed ID: 23370075
[TBL] [Abstract][Full Text] [Related]
16. Non-hormonal treatment of hot flushes in breast cancer survivors: gabapentin vs. vitamin E.
Biglia N; Sgandurra P; Peano E; Marenco D; Moggio G; Bounous V; Tomasi Cont N; Ponzone R; Sismondi P
Climacteric; 2009 Aug; 12(4):310-8. PubMed ID: 19415540
[TBL] [Abstract][Full Text] [Related]
17. Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial.
Pinkerton JV; Constantine G; Hwang E; Cheng RF;
Menopause; 2013 Jan; 20(1):28-37. PubMed ID: 23010882
[TBL] [Abstract][Full Text] [Related]
18. Treatment of partial seizures with gabapentin: double-blind, placebo-controlled, parallel-group study.
Yamauchi T; Kaneko S; Yagi K; Sase S
Psychiatry Clin Neurosci; 2006 Aug; 60(4):507-15. PubMed ID: 16884455
[TBL] [Abstract][Full Text] [Related]
19. Gabapentin vs. low-dose transdermal estradiol for treating post-menopausal women with moderate to very severe hot flushes.
Aguirre W; Chedraui P; Mendoza J; Ruilova I
Gynecol Endocrinol; 2010 May; 26(5):333-7. PubMed ID: 20050764
[TBL] [Abstract][Full Text] [Related]
20. Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation Study-NCCTG Trial N00CB.
Moraska AR; Atherton PJ; Szydlo DW; Barton DL; Stella PJ; Rowland KM; Schaefer PL; Krook J; Bearden JD; Loprinzi CL
J Support Oncol; 2010; 8(3):128-32. PubMed ID: 20552926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
